Katharina Skoll

Katharina Skoll

Auto-generated profile, based on publicly available information

Katharina Skoll

Division of Pharmaceutical Technology and Biopharmaceutics, Faculty of Life Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
KSKatharina Skoll
Katharina Skoll
MRMatthias Ritschka
Matthias Ritschka
SFStefanie Fuchs
Stefanie Fuchs
MWMichael Wirth
Michael Wirth
FGFranz Gabor
Franz Gabor
The focus of this study is the preparation of proteinaceous human serum albumin (HSA) nanocapsules with biocompatible plant oil cores avoiding toxic cross-linker and noxious non-aqueous liquids. The sonochemical preparation of HSA capsules with different plant oils yields particles with narrow size distribution forming suspensions stable for at least 14 days and enabling long-term storage by freezing. Furthermore, wheat germ agglutinin (WGA) as a targeting molecule was successfully embedded into the proteinaceous particle shell at a molar ratio of 7:1 (HSA/WGA). As urothelial cell binding studies revealed up to 55% higher cell binding potential of WGA-grafted particles than those without a targeter, targeted protein nanocapsules represent the first step towards new and innovative formulations.

13 November 2022 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
MAMaria Anzengruber
Maria Anzengruber
LWLukas Wimmer
Lukas Wimmer
RSRaffaela Szuchar
Raffaela Szuchar
KSKatharina Skoll
Katharina Skoll
MWMichael Wirth
Michael Wirth
FGFranz Gabor
Franz Gabor

4 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMaria Anzengruber
Maria Anzengruber
LNLisa Marie Nepustil
Lisa Marie Nepustil
FKFatlinda Kurtaj
Fatlinda Kurtaj
Ammar TahirAmmar Tahir
Ammar Tahir
KSKatharina Skoll
Katharina Skoll
FGFranz Gabor
Franz Gabor
Background: Most frequently the functionalization of nanoparticles is hampered by time-consuming, sometimes harsh conjugation and purification procedures causing premature drug release and/or degradation. A strategy to circumvent multi-step protocols is to synthesize building blocks with different functionalities and to use mixtures thereof for nanoparticle preparation in one step. Methods: BrijS20 was converted into an amine derivative via a carbamate linkage. The Brij-amine readily reacts with pre-activated carboxyl-containing ligands such as folic acid. The structures of the building blocks were confirmed by different spectroscopic methods and their utility was assessed by one-step preparation and characterization of nanoparticles applying PLGA as a matrix polymer. Results: Nanoparticles were about 200 nm in diameter independent of the composition. Experiments with human folate expressing single cells and monolayer revealed that the nanoparticle building block Brij mediates a “stealth” effect and the Brij-amine-folate a “targeting” effect. As compared to plain nanoparticles, the stealth effect decreased the cell interaction by 13%, but the targeting effect increased the cell interaction by 45% in the monolayer. Moreover, the targeting ligand density and thus the cell association of the nanoparticles is easily fine-tuned by selection of the initial ratio of the building blocks. Conclusions: This strategy might be a first step towards the one-step preparation of nanoparticles with tailored functionalities. Relying on a non-ionic surfactant is a versatile approach as it might be extended to other hydrophobic matrix polymers and promising targeting ligands from the biotech pipeline.